Alain Wilson

This profile gathers the share dealings of Alain Wilson in Antibe Therapeutics Inc. Between 19 September 2018 and 13 February 2024, the trades on record add up to 15 filings.

Every open-market trade on record is a purchase: 1 purchase worth €6,265, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 option exercises.

On 16 February 2024 came the latest disclosure, an option exercise for €32k in Antibe Therapeutics Inc. The clock since the last published purchase (19 September 2018) now reads 2,958 days. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.